What's breaking now, across thousands of outlets.
(MedPage Today) -- Phase II findings presented at the European Academy of Dermatology and Venereology meeting in Vienna showed promising early efficacy with abdakibart, an investigational interleukin (IL)-1 beta inhibitor, in patients with hidradenitis...
We haven't written up this one. MedPage Today has the full story — the link below goes straight to it.
(MedPage Today) -- The Pascal Precision transcatheter edge-to-edge repair (TEER) system eked out a win in symptomatic severe tricuspid regurgitation (TR) in its pivotal randomized trial.
Tuesday, November 17, 2026 In an effort to reach an elusive continuity of the self, some far-thinking technologists are working on ways to keep your brain going—even beyond death.
The Ebola virus can cause severe, often life-threatening disease in humans. To replicate, it must enter human cells and exploit their cellular processes.
A year ago, the rivalry between Eli Lilly and Novo was the fiercest in the industry. Now, it looks increasingly one-sided.
The nonprofits' deal, expected to close early next year, is the latest in a string of hospital divestitures from CommonSpirit Health.
New research suggests a healthier form of salt could prevent more than 10 million new cases of heart and kidney disease worldwide each year.
